FindTrial
Sign In

A comparative study of intralesional novel triple therapy injection Vs steroid injection in the treatment of keloid

Efficacy and side effects of Intralesional Novel Triple Medicine Combination Injections Vs Intralesional Triamcinolone Acetonide injections for the treatment of keloid. – A Randomized Control Trial. - Efficacy and side effects of Intralesional Novel Triple Medicine Combination Injections Vs Intralesional Triamcinolone Acetonide injections for the treatment of keloid. – A Randomized Control Tria

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061930
Enrollment
72
Registered
2024-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L918- Other hypertrophic disorders of the skin

Interventions

Intervention1: Intralesional Novel Triple Medicine Combination Injections: Intralesional Novel Triple Medicine Combination Injections done at every 3 weeks for 4 Sessions (0,3,6,9 weeks) and follow up

Sponsors

Aarupadai Veedu Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with keloids. 2.Age group of 15-65 years. 3.Both gender. 4.Consenting patients for the study.

Exclusion criteria

Exclusion criteria: 1.Pregnancy and lactating women. 2.Heart Disease. 3.Liver And Kidney Disease. 4.Immunocompromised patients. 5.H/O Previous treatment. 6.Non-compliant patients.

Design outcomes

Primary

MeasureTime frame
The Vancouver Scar Scale Score Primary outcome to assess treatment responseTimepoint: At Baseline 3weeks 9weeks 12 weeks & followed up further 3 months at monthly intervals—

Secondary

MeasureTime frame
Clinical Improvement based on Photographic DocumentTimepoint: At Baseline 3weeks 9weeks 12 weeks & followed up further 3 months at monthly intervals—

Countries

India

Contacts

Public ContactDamayandhi K

Aarupadai Veedu Medical College

deepakaliyaperumal@gmail.com9488511884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026